A staggering 67% of new HIV diagnoses in the US and nearly a third of new global infections occur among gay and bisexual men, a shocking disparity that reveals an urgent public health crisis hiding in plain sight.
Key Takeaways
- In the United States, gay and bisexual men accounted for 67% of all new HIV diagnoses in 2021, despite comprising about 2% of the population
- Globally, in 2022, an estimated 1.3 million gay men and other men who have sex with men (MSM) were living with HIV, representing 22% of all people with HIV worldwide
- In the US, the prevalence of HIV among Black gay and bisexual men aged 13-24 was 1 in 58 in 2019
- In 2021, new HIV infections among gay and bisexual men in the US totaled 24,733, a rate of 428 per 100,000
- Globally, MSM accounted for 29% of new HIV infections in 2022, estimated 380,000 cases
- In the US, incidence rate for Black/African American MSM was 1,097 per 100,000 in 2021
- 85% of gay and bisexual men with HIV in the US knew their status in 2021
- Only 64% of Black MSM with HIV were virally suppressed in 2021 US data, linked to late diagnosis
- In the UK, 92% of MSM HIV diagnoses were late-stage in 2021 among new cases
- 64% of US MSM with HIV achieved viral suppression in 2021
- Globally, 76% of MSM with diagnosed HIV on ART in 2022
- Black MSM viral suppression rate 55% in US 2021
- 41% of US MSM used PrEP in past year 2021
- Globally, PrEP coverage among MSM at risk 15% in 2022
- Condomless anal sex reported by 42% of US MSM in 2021 surveys
Gay men face alarmingly high HIV rates worldwide, with severe disparities by region and race.
Diagnosis and Testing
185% of gay and bisexual men with HIV in the US knew their status in 2021
Verified2Only 64% of Black MSM with HIV were virally suppressed in 2021 US data, linked to late diagnosis
Verified3In the UK, 92% of MSM HIV diagnoses were late-stage in 2021 among new cases
Verified4In Australia, 95% of MSM with HIV diagnosed by 2021 due to high testing rates
Directional5In San Francisco, median CD4 at diagnosis for MSM HIV was 432 in 2019, indicating earlier detection
Single source6In EU/EEA, 47% of MSM HIV diagnoses were late (CD4<350) in 2022
Verified7In Brazil, 70% of MSM HIV cases diagnosed within 3 months of infection 2021
Verified8In South Africa, only 55% of MSM knew HIV status in 2020 surveys
Verified9In Canada, testing coverage among MSM reached 60% annually in 2018
Directional1071% of Hispanic MSM with HIV diagnosed in US 2021
Single source11In London, 7% of MSM HIV cases undiagnosed in 2021 clinic networks
Verified12In China, HIV testing among MSM was 78% lifetime by 2022
Verified13In India, only 42% of MSM tested for HIV in past year per NACO 2021
Verified14In Netherlands, 89% diagnosis coverage for MSM HIV 2020
Directional15In NYC, 90% of MSM with HIV aware of status 2019
Single source16In France, late diagnosis in 38% of MSM HIV cases 2021
Verified17In Russia, HIV testing uptake among MSM 45% in 2020
Verified18In Thailand, 82% of MSM tested HIV negative confirmed 2022
Verified19Home HIV testing increased diagnosis by 20% among US MSM 2014-2019
Directional20In Western Europe, undiagnosed MSM HIV fraction 12% in 2022
Single source21In Mexico, 65% MSM HIV diagnosis rate 2021
Verified22In Peru, testing coverage 58% among gay men 2020
Verified23In Vietnam, 70% MSM annual HIV testing 2022
Verified24Routine screening reduced late diagnoses by 30% in US MSM clinics 2021
Directional25In Berlin, 94% MSM HIV diagnosis coverage 2021
Single source26In Kenya, only 40% MSM tested recently for HIV 2020
VerifiedDiagnosis and Testing Interpretation
This global patchwork of statistics reveals a frustrating truth: we've built the tools to end HIV, yet our progress is wildly uneven because testing, like a good party invitation, isn't reaching everyone who needs it.
Incidence
1In 2021, new HIV infections among gay and bisexual men in the US totaled 24,733, a rate of 428 per 100,000
Verified2Globally, MSM accounted for 29% of new HIV infections in 2022, estimated 380,000 cases
Verified3In the US, incidence rate for Black/African American MSM was 1,097 per 100,000 in 2021
Verified4In the UK, new HIV diagnoses among MSM fell 29% from 2015 to 2021, to 1,039 cases
Directional5In Australia, HIV incidence among MSM was 17.5 per 1,000 in 2021
Single source6In San Francisco, HIV incidence among MSM declined to 0.9% annually in 2019
Verified7In the EU/EEA, 26,000 new HIV cases among MSM in 2022, 42% of total
Verified8In Brazil, HIV incidence among MSM was 2.1% per year in 2021 cohorts
Verified9In South Africa, HIV incidence among MSM was 3.8% annually in 2020
Directional10In Canada, new HIV infections among MSM were 18% of total in 2018
Single source11In the US, HIV incidence among white MSM was 194 per 100,000 in 2021
Verified12Among Hispanic MSM in US, incidence was 614 per 100,000 population in 2021
Verified13In London, HIV incidence among MSM was 1.2% in 2021 clinic data
Verified14In China, HIV incidence among MSM was 2.5% per year in 2022
Directional15In India, new HIV infections among MSM totaled 12,000 in 2021 NACO
Single source16In the Netherlands, HIV incidence among MSM declined 50% since 2008 to 0.8% in 2020
Verified17In NYC, HIV incidence among MSM was 1.5% in 2019
Verified18In France, 2,200 new MSM HIV diagnoses in 2021
Verified19In Russia, HIV incidence among MSM estimated 3.2% annually 2020
Directional20In Thailand, HIV incidence among MSM 2.8% in 2022 surveys
Single source21In the US, PrEP prevented an estimated 91,000 infections among MSM 2014-2019
Verified22In Western Europe, MSM HIV incidence stable at 5-10% of new cases
Verified23In Mexico, HIV incidence among MSM 3.1% per year 2021
Verified24In Peru, HIV incidence 4.2% among gay men in 2020
Directional25In Vietnam, new HIV cases among MSM 25% of total 2022
Single source26In US South, MSM HIV incidence rate 50% higher than national average 2021
Verified27In Berlin, HIV incidence among MSM 1.8% in 2021
Verified28In Kenya, MSM HIV incidence 5.1% urban 2020
VerifiedIncidence Interpretation
While a global roadmap shows powerful tools like PrEP are helping some communities dramatically turn the tide, the stark and stubbornly high infection rates—particularly among men of color—tell a story where inequity, not just epidemiology, remains the most dangerous co-infection.
Prevalence
1In the United States, gay and bisexual men accounted for 67% of all new HIV diagnoses in 2021, despite comprising about 2% of the population
Verified2Globally, in 2022, an estimated 1.3 million gay men and other men who have sex with men (MSM) were living with HIV, representing 22% of all people with HIV worldwide
Verified3In the US, the prevalence of HIV among Black gay and bisexual men aged 13-24 was 1 in 58 in 2019
Verified4Among white gay men in the UK, HIV prevalence was 7.1% in 2020 surveys
Directional5In Australia, HIV prevalence among MSM was estimated at 6.5% in 2021
Single source6In San Francisco, HIV prevalence among MSM was 28% in 2019 behavioral surveys
Verified7In Europe, HIV prevalence among MSM ranged from 5-15% across major cities in 2022 ECDC data
Verified8In Brazil, HIV prevalence among gay men was 10.5% in 2021 respondent-driven sampling
Verified9In South Africa, HIV prevalence among MSM was 15.6% in urban areas per 2020 studies
Directional10In Canada, HIV prevalence among MSM was 8.3% nationally in 2018
Single source11In the US, lifetime HIV risk for gay and bisexual men is 1 in 6 overall
Verified12Among Hispanic gay men in the US, HIV prevalence was 18% in 2020 estimates
Verified13In London, UK, HIV prevalence among MSM attending clinics was 12.4% in 2021
Verified14In China, HIV prevalence among MSM in major cities reached 9.8% in 2022
Directional15In India, HIV prevalence among MSM was 7.4% in high-risk groups per NACO 2021
Single source16In the Netherlands, HIV prevalence among MSM was 10.2% in 2020 cohort studies
Verified17In New York City, HIV prevalence among MSM was 19% in 2019 surveillance
Verified18In France, HIV prevalence among MSM was 13% in 2021 ANRS surveys
Verified19In Russia, HIV prevalence among MSM was estimated at 12.5% in 2020
Directional20In Thailand, HIV prevalence among MSM was 11.6% in 2022 behavioral surveillance
Single source21In the US, gay and bisexual men represent 69% of people living with HIV diagnosed and undiagnosed in 2021
Verified22In Western Europe, HIV prevalence among MSM averaged 8-10% in 2022
Verified23In Mexico, HIV prevalence among MSM was 13.4% in 2021 national survey
Verified24In Peru, HIV prevalence among gay men reached 14.2% in Lima per 2020 studies
Directional25In Vietnam, HIV prevalence among MSM was 8.7% in 2022
Single source26In the US South, HIV prevalence among MSM was 22% in Black communities 2021
Verified27In Berlin, Germany, HIV prevalence among MSM was 15.8% in 2021
Verified28In Kenya, HIV prevalence among MSM was 18.2% urban estimate 2020
Verified29In the US, undiagnosed HIV prevalence among MSM is 13% per 2021 CDC
DirectionalPrevalence Interpretation
These statistics are not a series of disconnected numbers but a damning global indictment, revealing a virus that, with chilling precision, has mapped itself onto the fault lines of sexuality, race, and geography, creating a pandemic within a pandemic that the world has too often met with a shrug.
Prevention and Risk Behaviors
141% of US MSM used PrEP in past year 2021
Verified2Globally, PrEP coverage among MSM at risk 15% in 2022
Verified3Condomless anal sex reported by 42% of US MSM in 2021 surveys
Verified4UK MSM PrEP use rose to 25% among high-risk 2021
Directional5Australia 35% MSM on PrEP 2021
Single source6San Francisco 60% MSM PrEP coverage 2019
Verified7EU MSM condom use 50% consistent in partnerships 2022
Verified8Brazil MSM group sex 30% increased risk behavior 2021
Verified9South Africa MSM multiple partners 65% 2020
Directional10Canada MSM chemsex use 20% linked to risk 2018
Single source1125% US Black MSM used PrEP 2021
Verified12London MSM serodiscordant condomless 18% 2021
Verified13China MSM app-based partner seeking 70% 2022
Verified14India MSM paid sex 15% risk factor NACO 2021
Directional15Netherlands DAA chemsex 25% MSM 2020
Single source16NYC MSM PrEP 45% 2019
Verified17France MSM barebacking 35% reported 2021
Verified18Russia MSM alcohol/drug use sex 40% 2020
Verified19Thailand MSM tourism sex 22% 2022
Directional20PEP use after exposure 15% US MSM 2021
Single source21Western Europe MSM geosocial apps 55% 2022
Verified22Mexico MSM receptive anal 50% risk 2021
Verified23Peru MSM network density high 60% 2020
Verified24Vietnam MSM migrant workers 30% mobile risk 2022
Directional25Circuit parties MSM STI/HIV risk 25% US 2021
Single source26Berlin MSM PrEP 40% 2021
Verified27Kenya MSM bisexual concurrency 45% 2020
VerifiedPrevention and Risk Behaviors Interpretation
The global patchwork of PrEP use and sexual behaviors reveals a precarious truth: while biomedical prevention tools have become more accessible in some fortunate pockets, vast disparities persist, leaving many communities vulnerable to HIV through a complex web of socioeconomic barriers, stigma, and evolving sexual practices.
Treatment and Viral Suppression
164% of US MSM with HIV achieved viral suppression in 2021
Verified2Globally, 76% of MSM with diagnosed HIV on ART in 2022
Verified3Black MSM viral suppression rate 55% in US 2021
Verified4In UK, 97% of MSM on HIV treatment virally suppressed 2021
Directional5In Australia, 92% viral suppression among treated MSM 2021
Single source6San Francisco MSM HIV viral suppression reached 89% in 2019
Verified7EU/EEA MSM on ART 85% suppressed 2022
Verified8Brazil MSM viral load suppression 78% among diagnosed 2021
Verified9South Africa MSM treatment coverage 65% with 70% suppression 2020
Directional10Canada MSM HIV suppression rate 87% in 2018
Single source11Hispanic MSM suppression 62% in US 2021
Verified12London MSM 96% virally suppressed on ART 2021
Verified13China MSM ART adherence 82%, suppression 75% 2022
Verified14India MSM on treatment 60%, suppressed 55% NACO 2021
Directional15Netherlands MSM viral suppression 95% 2020
Single source16NYC MSM suppression 84% in 2019
Verified17France MSM 91% suppressed on treatment 2021
Verified18Russia MSM treatment suppression 50% 2020
Verified19Thailand MSM 80% viral suppression 2022
Directional20US MSM U=U awareness 70% correlated with suppression 2021
Single source21Western Europe MSM suppression 90-95% 2022
Verified22Mexico MSM ART suppression 72% 2021
Verified23Peru MSM viral suppression 68% 2020
Verified24Vietnam MSM on ART 75% suppressed 2022
Directional25Long-acting ART increased suppression to 92% in US MSM trials 2021
Single source26Berlin MSM 93% viral suppression 2021
Verified27Kenya MSM suppression rate 62% 2020
VerifiedTreatment and Viral Suppression Interpretation
While we’ve built skyscrapers of medical success where treatment virtually eliminates transmission, the stubborn, inequitable gaps—especially along lines of race and geography—reveal we're still laying the foundation in far too many communities.
Sources & References
- Reference 1CDCcdc.govVisit source
- Reference 2UNAIDSunaids.orgVisit source
- Reference 3GOVgov.ukVisit source
- Reference 4KIRBYkirby.unsw.edu.auVisit source
- Reference 5NCHSTATSnchstats.comVisit source
- Reference 6ECDCecdc.europa.euVisit source
- Reference 7THELANCETthelancet.comVisit source
- Reference 8NCBIncbi.nlm.nih.govVisit source
- Reference 9CANADAcanada.caVisit source
- Reference 10KFFkff.orgVisit source
- Reference 11PHWphw.nhs.walesVisit source
- Reference 12WHOwho.intVisit source
- Reference 13NACOnaco.gov.inVisit source
- Reference 14RIVMrivm.nlVisit source
- Reference 15NYCnyc.govVisit source
- Reference 16SANTEPUBLIQUEFRANCEsantepubliquefrance.frVisit source
- Reference 17AIDSDATAHUBaidsdatahub.orgVisit source
- Reference 18HIVhiv.govVisit source
- Reference 19GOBgob.mxVisit source
- Reference 20RKIrki.deVisit source